Celgene has promoted Wim Souverijns to general manager for its operations in the UK and Ireland.
Souverijns replaces Samantha Pearce, who has moved to a new role at Celgene as VP and general manager for emerging markets in the EMEA region.
Souverijns joined Celgene in 2007 as head of the European marketing operations team. He later moved to a position in the US before returning to Europe to his most recent role as general manager for the Nordics region.
Commenting on his appointment, Souverijns said: “I am excited to have the opportunity to build on recent successes and commit to engage in a collaborative partnership with patients, clinicians, payers and other stakeholders to ensure that all eligible patients have access to our treatments.
“This is even more pertinent with the recent changes to the Cancer Drugs Fund, which I strongly hope will enable patients with myeloma and metastatic pancreatic cancer to continue to be able to access treatments that can make a real difference to their lives.”
Celgene said Souverijns will look to strengthen the firm’s relationship with the NHS and other important external partners to highlight the positive effect the industry has on patients and their families.